Clinical Trial Update: Long-term Study of Duodopa (Levodopa/Carbidopa) in Advanced Parkinson's: Health Outcomes & Net Economic Impact [Phase 4]

View source ↗

Summary

Phase 4 long-term study of Duodopa (levodopa/carbidopa) in advanced Parkinson's disease reports health outcomes and net economic impact; results were posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Duodopa (carbidopa/levodopa intestinal gel)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Advanced Idiopathic Parkinson's Disease | Phase 4 | Status: COMPLETED | Results posted: 2016-07-18